We have launched two innovative clinical research studies aiming to improve the experience of people living with multiple sclerosis.

Multiple sclerosis (MS) is a condition that affects the brain and spinal cord. While it cannot currently be cured, treatment can often help manage the symptoms.

There are three main types of MS, which affect people in different ways.

• Relapsing multiple sclerosis is where someone has flare-ups of symptoms where they get worse (relapse) and then go away or get better (remission). Over time, this type often develops into secondary progressive MS.
• Secondary progressive multiple sclerosis is where symptoms are there all the time, and get slowly worse.
• Primary progressive multiple sclerosis is where symptoms slowly get worse over time with no periods of remission. This is less common than other types of MS.

About the clinical research studies

The FREVIVA trial is designed for men and women between the ages of 18 and 60 diagnosed with secondary progressive multiple sclerosis (SPMS).

Read more

The FREXALT trial is designed for men and women between the ages of 18 and 55 diagnosed with relapsing multiple sclerosis (RMS).

Read more

Get in touch with our friendly team and discover how you can take part:

crf@exeter.ac.uk  

Discover more clinical research opportunities here.